F

Flagship Pioneering

Venture capital building bioplatform companies

Molecular Biology Co-op

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Internship · Winter 2027Cambridge, MA, USA$25 - $35 /hr

About the Job

Requirements

  • The candidate must be a current Northeastern University co-op student.
  • The candidate must be pursuing an MS in Molecular Biology, Cell Biology, Bioengineering, Biochemistry, or a related field.
  • The candidate must have a strong foundation in molecular biology and cell culture.
  • The candidate must have hands-on experience with miniprep/midiprep, polymerase chain reaction (PCR), agarose gel electrophoresis, restriction enzyme digests, ligation, and DNA purification.
  • The candidate must have strong organizational skills, attention to detail, and clear written and verbal communication.

Responsibilities

  • Design, build, and quality-control DNA constructs using restriction cloning, Gibson assembly, Golden Gate assembly, and polymerase chain reaction (PCR).
  • Run agarose DNA gels to analyze PCR products and digests, and perform gel extraction and DNA purification.
  • Set up restriction enzyme digests and ligations, optimize reaction conditions, and troubleshoot cloning workflows.
  • Perform core molecular and cell biology tasks, including DNA and RNA extraction, quantitative PCR (qPCR), reverse-transcription quantitative PCR (RT-qPCR), transfection, transduction, and clonal line generation.
  • Analyze and clearly communicate experimental results, and iterate protocols in collaboration with experienced scientists.

Desired Qualifications

  • Experience with synthetic biology, genome engineering, or assay development is a plus.

About the Company

Flagship Pioneering

Venture capital building bioplatform companies

Flagship Pioneering funds and incubates life-sciences ventures by creating bioplatform companies, forming early-stage NewCos and helping them grow into GrowthCos. It identifies broad scientific platforms that can spawn multiple products and builds companies around those platforms to move them from inception to growth. The firm Differentiates itself by actively creating and guiding new platform-based ventures from scratch, rather than only investing in existing companies, building a diverse pipeline of category leaders. Its goal is to develop a portfolio of platform-based biotechnology and life-science companies that deliver multiple products and advance human health and sustainability.

Company size
501-1,000
Company stage
Not listed
Total funding
$11.5B
Headquarters
Cambridge, MD
Founded
2000

Recently Posted Jobs

Explore more opportunities at Flagship Pioneering

See more jobs